=== OFFICIAL TITLE ===
To maximize discovery, and accelerate development and availability, of promising childhood cancer treatments, and for other purposes.

=== STRUCTURED BODY ===
    1.
    Header: Short title
    This Act may be cited as the
        Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022
    or the
        Childhood Cancer STAR Reauthorization Act
    .
    2.
    Header: Reauthorizing and improving the Childhood STAR Act
      (a)
      Header: Children's cancer biorepositories
      Section 417E of the Public Health Service Act (
        42 U.S.C. 285a–11
      ) is amended—
        (1)
        in subsection (a)—
          (A)
          in paragraph (2)(A), by inserting before the period at the end of the second sentence the following:
            , such as collected samples of both solid tumor cancer and paired samples
          ;
          (B)
          in paragraph (9), by striking
            Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018
          and inserting
            Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022
          ;
          (C)
          by redesignating paragraph (10) as paragraph (11); and
          (D)
          by inserting after paragraph (9) the following:
              (10)
              Header: Report on researcher access to children's cancer biorepository samples
              Not later than 2 years after the date of enactment of the
                Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022
              , the Director of NIH shall—
                (A)
                conduct a review of the procedures established under paragraph (2)(C) and other policies or procedures related to researcher access to such biospecimens to identify any opportunities to reduce administrative burden, consistent with paragraph (2)(D), in a manner that protects personal privacy to the extent required by applicable Federal and State privacy law, at a minimum; and
                (B)
                submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report on the findings of the review under subparagraph (A) and whether the Director of NIH plans to make any changes to the policies or procedures considered in such review, based on such findings.
            ; and
        (2)
        in subsection (d), by striking
          2019 through 2023
        and inserting
          2024 through 2028
        .
      (b)
      Header: Cancer survivorship programs
      Section 201 of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018 (
        Public Law 115–180
      ) is amended—
        (1)
        in subsection (a)—
          (A)
          in the subsection heading, by striking
              Pilot programs to explore
          and inserting
              Research to evaluate
          (B)
          in paragraph (1)—
            (i)
            by striking
              may make awards to eligible entities to establish pilot programs
            and inserting
              shall, as appropriate, make awards to eligible entities to conduct or support research
            ;
            (ii)
            by striking
              model systems
            and inserting
              approaches
            ;
            (iii)
            by inserting
              and adolescent
            after
              childhood
            ; and
            (iv)
            by striking
              evaluation of models for
            ;
          (C)
          in paragraph (2)—
            (i)
            in subparagraph (A), in the matter preceding clause (i), by inserting
              within the existing peer review process,
            after
              practicable,
            ; and
            (ii)
            in subparagraph (B)(v), by striking
              in treating survivors of childhood cancers
            and inserting
              in carrying out the activities described in paragraph (1)
            ; and
          (D)
          in paragraph (3)(B)(v), by striking
            design of systems for the effective transfer of treatment information and care summaries from cancer care providers to other health care providers
          and inserting
            design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts
          ; and
        (2)
        in subsection (b)—
          (A)
          in each of paragraphs (1) and (2), by striking
            date of enactment of this Act
          and inserting
            date of enactment of the
              Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022
          ; and
          (B)
          in paragraph (1)—
            (i)
            by striking subparagraphs (A) and (C);
            (ii)
            by redesignating subparagraph (B) as subparagraph (A); and
            (iii)
            by adding at the end the following:
                (B)
                recommendations for enhancing or promoting activities of the Department of Health and Human Services related to workforce development for health care providers who provide psychosocial care to pediatric cancer patients and survivors.
              .
